IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

TRV GP III, LLC

Q1 2022 Holdings

Filed 2022-05-10 | 7 holdings | $368.5K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Revolution Medicines, Inc.(RVMD)COM76155X100$140.9K5,524,03138.2%
Fulcrum Therapeutics, Inc.(FULC)COM359616109$93.7K3,962,20225.4%
Voyager Therapeutics, Inc.(VYGR)COM92915B106$48.7K6,391,17613.2%
Pliant Therapeutics, Inc.(PLRX)COM729139105$40.9K5,839,16011.1%
Nurix Therapeutics, Inc.(NRIX)COM67080M103$26.9K1,922,5497.3%
Decibel Therapeutics, Inc.COM24343R106$9.5K3,139,6852.6%
Jounce Therapeutics, Inc.(JNCEEUR)COM481116101$7.8K1,148,7802.1%